Correction to: The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages (BMC Cancer, (2020), 20, 1, (836), 10.1186/s12885-020-07228-y)

Elnaz Shirmohammadi; Seyed Esmaeil Sadat Ebrahimi; Amir Farshchi; Mona Salimi

ArticleOPEN ACCESS

Correction to: The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages (BMC Cancer, (2020), 20, 1, (836), 10.1186/s12885-020-07228-y)

BMC Cancer

DOI: 10.1186/s12885-020-07641-3

1Citations

7Readers

Abstract

Following publication of the original article [1], the authors report the following errors in their article:.

Cite

CITATION STYLE

APA

Shirmohammadi, E., Ebrahimi, S. E. S., Farshchi, A., & Salimi, M. (2020, December 1). Correction to: The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages (BMC Cancer, (2020), 20, 1, (836), 10.1186/s12885-020-07228-y). BMC Cancer. BioMed Central Ltd. https://doi.org/10.1186/s12885-020-07641-3

Correction to: The efficacy of etanercept as anti-breast cancer treatment is attenuated by residing macrophages (BMC Cancer, (2020), 20, 1, (836), 10.1186/s12885-020-07228-y)

Abstract

Cite

Register to see more suggestions